Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
An antianalgesic action of intracerebroventricularly administered nociceptin was elicited against intrathecal morphine-induced antinociception in the tail-flick test in mice and investigated as a descending neuronal system for the spinal mediator involved. The nociceptin-induced antianalgesia originating in the brain was inhibited by intrathecally administered indomethacin and suggested the mediation of spinal prostaglandin. The antianalgesic action of intracerebroventricular nociceptin was closely matched by intrathecal prostaglandin (PG) E(2). Both shifted the dose-response curve of morphine to the right and these actions were eliminated by intrathecal PGD(2.) Desensitization of the antianalgesic action of PGE(2) by intrathecal PGE(2) pretreatment also produced cross-desensitization to the antianalgesic action of intracerebroventricular nociceptin. Neither intracerebroventricular nociceptin nor intrathecal PGE(2) produced antianalgesia against the delta-receptor agonists given intrathecally. Thus, the antianalgesic action of nociceptin originating in the brain is coupled to a descending neuronal pathway mediated by spinal PGE(2).
Rady
J J
JJ
Research Service, Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA.
Campbell
W B
WB
Fujimoto
J M
JM
D000701:Analgesics, Opioid / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000378:metabolism / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D020881:Enkephalin, D-Penicillamine (2,5)- / Q000494:pharmacology; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D018847:Opioid Peptides / Q000008:administration & dosage / Q000494:pharmacology*; D010147:Pain Measurement; D011982:Receptors, Prostaglandin / Q000502:physiology; D013116:Spinal Cord / Q000378:metabolism / Q000502:physiology*; D013373:Substance P / Q000494:pharmacology; D000097629:Nociceptin
D000701:Analgesics, Opioid; D016861:Cyclooxygenase Inhibitors; D015232:Dinoprostone; D020881:Enkephalin, D-Penicillamine (2,5)-; D004743:Enkephalin, Leucine; D007213:Indomethacin; D009020:Morphine; D018847:Opioid Peptides; D011982:Receptors, Prostaglandin; D013373:Substance P; D000097629:Nociceptin; C034318:enkephalin, Ser(2), Leu(5), Thr(6)-